<DOC>
	<DOCNO>NCT00114543</DOCNO>
	<brief_summary>This multi-center , randomize clinical trial compare different bilirubin level threshold time phototherapy extremely low birth weight infant . The primary hypothesis would difference death neurodevelopmental impairment 18-22 month correct age infant treat either aggressive conservative threshold limit . 1,978 infant enrol .</brief_summary>
	<brief_title>Trial Aggressive Versus Conservative Phototherapy Infants &lt; 1,000 Grams Birth Weight</brief_title>
	<detailed_description>In NICHD Neonatal Research Network ( NRN ) center 2002 , phototherapy administer 94 percent extremely low birth weight ( ELBW ) infant survive 12 hour . Yet , unclear level bilirubin blood harmful tiny infant -- data exist large recent clinical trial define risk , benefit , appropriate indication phototherapy infant . The large recent trial NICHD Collaborative Phototherapy Trial involve infant treat 1974-1976 include 77 ELBW infant . Data study others suggest phototherapy could important hazard well benefit ELBW infant . This NRN study use two different bilirubin level threshold time phototherapy 1,978 extremely low birth weight infant , examine primary hypothesis would difference death neurodevelopmental impairment 18-22 month correct age aggressively conservatively treated group . Enrolled infant stratify birth weight ( 501-750g 751-1,000g ) randomize receive phototherapy regimen base either aggressive threshold conservative threshold total serum bilirubin . In Aggressive group : - 501-750 gram birth weight infant , phototherapy start , stop , restart base total serum bilirubin threshold level 5 mg/dl day life 1-14 . - 751-1,000 gram birth weight infant , phototherapy start , stop , restart base total serum bilirubin threshold level 5 mg/dl day life 1-7 7 mg/dl day life 8-14 . In Conservative group : - 501-750 gram birth weight infant , phototherapy start , stop , restart base total serum bilirubin threshold level 8 mg/dl day life 1-14 . - 751-1,000 gram birth weight infant , phototherapy start , stop , restart base total serum bilirubin threshold level 10 mg/dl day life 1-14 . The phototherapy regimen design fall within range clinical practice assure sizable difference group total serum bilirubin level duration phototherapy . The primary outcome death neurodevelopmental impairment 18-22 month correct age determine outpatient clinic visit . Secondary outcome include death , abnormal neurodevelopmental outcome , severe hearing loss , cerebral palsy , blindness , important medical outcome .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Hyperbilirubinemia , Neonatal</mesh_term>
	<mesh_term>Jaundice , Neonatal</mesh_term>
	<mesh_term>Bilirubin</mesh_term>
	<criteria>Inclusion criterion : 5011000 gram birth weight 1236 hour postnatal age Exclusion criterion : Terminal condition ( pH &lt; 6.8 &gt; 2 hour OR persistent bradycardia , heart rate &lt; 100 bpm , associate hypoxia &gt; 2 hour ] Prior use phototherapy Major congenital anomaly Hydrops fetalis severe hemolytic disease diagnose inutero Overt congenital nonbacterial infection Parental refusal inability provide consent Attending physician refusal Parents consider unlikely return followup evaluation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Hours</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Bilirubin</keyword>
	<keyword>Phototherapy</keyword>
	<keyword>Very Low Birth Weight ( VLBW )</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW )</keyword>
	<keyword>Prematurity</keyword>
	<keyword>Neurodevelopmental outcome</keyword>
</DOC>